Literature DB >> 7327245

Antagonistic activity of galanthamine on constant infusion of pancuronium in rats.

D A Cozanitis, F van de Pol, H van Wezel, J F Crul.   

Abstract

The effect of galanthamine, an anticholinesterase having a tertiary ammonium group, on a constant infusion of pancuronium was studied in the rat tibialis anterior-sciatic nerve preparation. The results were compared with those previously obtained with neostigmine, pyridostigmine, and 4-aminopyridine. The antagonizing activity of galanthamine is similar to that of 4-aminopyridine and less than that of the other 2 anticholinesterases. The duration of galanthamine antagonism is similar to that of neostigmine and pyridostigmine but less than that of 4-aminopyridine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7327245     DOI: 10.1007/bf01948388

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  7 in total

1.  The effect of anti-cholinesterase agents on the rat's blood pressure.

Authors:  P DIRNHUBER; H CULLUMBINE
Journal:  Br J Pharmacol Chemother       Date:  1955-03

2.  The potency ratio of galanthamine and neostigmine on the reversal of the tubocurarine block in the isolated rat diaphragm.

Authors:  D A Cozanitis
Journal:  Acta Anaesthesiol Belg       Date:  1977

3.  Potentiation of neostigmine and pyridostigmine by 4-aminopyridine in the rat.

Authors:  R D Miller; P A Dennissen; F van der Pol; S Agoston; L H Booij; J F Crul
Journal:  J Pharm Pharmacol       Date:  1978-11       Impact factor: 3.765

4.  Galanthamine versus neostigmine for reversal of nondepolarizing neuromuscular block in man.

Authors:  A Baraka; D Cozanitis
Journal:  Anesth Analg       Date:  1973 Sep-Oct       Impact factor: 5.108

5.  Clinical experiences with diallyl-nor-toxiferine and the curare antidote galanthamine.

Authors:  O Mayrhofer
Journal:  South Med J       Date:  1966-11       Impact factor: 0.954

6.  Reversal of central anticholinergic syndrome by galanthamine.

Authors:  A Baraka; S Harik
Journal:  JAMA       Date:  1977-11-21       Impact factor: 56.272

7.  Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine).

Authors:  D A Cozanitis
Journal:  Anaesthesist       Date:  1977-12       Impact factor: 1.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.